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PWhen Children With Kawasaki Disease Grow Up
Myocardial and Vascular Complications in Adulthood
John B. Gordon, MD,* Andrew M. Kahn, MD, PHD,† Jane C. Burns, MD‡
San Diego, California
Kawasaki disease (KD) is an acute, self-limited vasculitis that typically occurs in young children and was first
described by Japanese pediatrician Tomisaku Kawasaki in 1967. Although originally thought to be a rare condi-
tion, KD has become the most common cause of acquired heart disease in the pediatric age group in developed
countries. The majority of patients with KD appear to have a benign prognosis, but a subset of patients with cor-
onary artery aneurysms are at risk for ischemic events and require lifelong treatment. In the 4 decades that
have passed since the initial recognition of KD, the number of patients reaching adulthood has continued to
grow. Adult cardiologists will be increasingly involved in the management of these patients. Currently, there
are no established guidelines for the evaluation and treatment of adult patients who have had KD. We review
here the current literature that may be helpful to clinicians who care for adults who experienced KD in
childhood. (J Am Coll Cardiol 2009;54:1911–20) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.102r
f
c
E
I
i
a
m
S
l
t
i
i
r
s
a
4
o
e
p
c
a
w
s
q
e
p
o
bawasaki disease (KD) is the leading cause of acquired heart
isease in children in the developed world (1). Typically, KD
resents in children younger than 5 years of age as a febrile
llness with mucocutaneous changes (2). A subset of patients
ill develop permanent damage to the arterial wall, valve
eaflets, and myocardium. The acute phase of the illness is
elf-limited, and the diagnosis may be missed. If untreated,
D can result in coronary aneurysms in 25% of patients (3).
atients who experience coronary artery damage may develop
hrombosis or stenotic lesions associated with the aneurysms
nd are at risk of myocardial infarction, sudden death, and
ongestive heart failure (4,5). The prognosis for adults who
ave recovered from KD without coronary aneurysms is
ostulated to be good, but longitudinal studies have not been
erformed to test this hypothesis.
In 2004, the American Heart Association (AHA) issued
pdated guidelines for the care and management of children
ith KD (6). However, studies of the optimal therapy and
anagement of the sequelae of KD in adults have not been
erformed, nor have official guidelines been developed that
rovide direction for cardiologists as they begin to care for
he growing number of young adults who experienced KD
n childhood. The available data suggest that the patho-
hysiology of the vascular lesion in KD is unique and
istinct from atherosclerosis. Here, we undertake a critical
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grant from the National Institutes of Health, Heart, Lung, Blood Institute to Dr.
urns (RO1-HL69413). Masato Takahashi, MD, served as Guest Editor for this
rticle.a
Manuscript received August 25, 2008; revised manuscript received March 25, 2009,
ccepted April 17, 2009.eview of the literature describing the cardiovascular mani-
estations in young adults who experienced KD in
hildhood.
pidemiology and Clinical Aspects of Acute KD
t is estimated that 4,000 new cases of KD are diagnosed
n the U.S. each year (7). In Japan, where the incidence is
pproximately 10-fold greater as compared with the U.S.,
ore than 10,000 new cases are diagnosed each year (8).
easonality of cases, nationwide epidemics, and the self-
imited nature of the acute illness suggest an infectious
rigger, but no causative agent has been identified. Genetic
nfluences on disease susceptibility and outcome have been
dentified, and the current paradigm proposes that KD
esults from exposure to a common agent that triggers the
yndrome only in genetically susceptible hosts (9–11).
The self-limited clinical syndrome is recognized through
constellation of clinical signs that include fever for at least
days associated with rash, conjunctival injection, erythema
f the lips and oropharynx, edema of the hands and feet,
rythema of the palms and soles, and, in the convalescent
hase, periungual desquamation (6). Up to 25% of untreated
hildren will develop permanent damage to the coronary
rteries with inflammatory cell infiltration of the arterial
all, destruction of the internal elastic lamina, necrosis of
mooth muscle cells, myointimal proliferation, and subse-
uent aneurysm formation (3,12). Aneurysms of systemic,
xtraparenchymal muscular arteries also occur in a subset of
atients with coronary aneurysms (13). The proximal cor-
nary arteries can be readily imaged in infants and children
y the use of transthoracic echocardiography, which permits
reliable and reproducible measurement of the internal
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Sequelae of Kawasaki Disease in Adults November 17, 2009:1911–20diameter of the proximal right
and left anterior descending cor-
onary arteries and the expression
of these measurements as stan-
dard deviation units (Z score)
normalized for body surface area
(14–16).
Administration of a single dose
of intravenous immunoglobulin
(IVIG) in conjunction with aspirin
within the first 10 days after fever
onset reduces the incidence of an-
eurysms from 25% to 3% to 5%
(17,18). The AHA guidelines
have categorized these patients
into 5 groups on the basis of cor-
onary artery Z scores and mor-
hology of the coronary artery lesions (Table 1) (6). Approx-
mately 30% of IVIG-treated children with KD will develop
ransient dilation of the coronary arteries (Z score2.5 for the
ight coronary artery or left anterior descending artery, AHA
isk level II) (16,19). Another 5% to 10% will develop coronary
rtery aneurysms, which in some cases can be attributed to
elayed diagnosis and treatment. There are no data regarding
he number of young adults in the U.S. who experienced KD
n childhood. If we estimate 4,000 KD patients/year in the
.S. beginning in 1986 when IVIG treatment was first
ecommended, assume an average age of onset of 2 years, a rate
f 30% for coronary artery dilation, and 5% for aneurysms, then
here are currently 24,000 young adults (18 years) who have
Abbreviations
and Acronyms
AHA  American Heart
Association
CT  computed
tomography
IMT  intimal medial
thickness
IVIG  intravenous
immunoglobulin
KD  Kawasaki disease
LOE  Level of Evidence
MR  magnetic resonance
SMR  standardized
mortality ratio
merican Heart Association Risk Stratification for Kawasaki DiseaTable 1 American Heart Association Risk Stratification for Kaw
Risk Level Pharmacological Therapy
I (no coronary artery changes
at any stage of illness)
None beyond first 6–8 weeks
II (transient coronary artery
ectasia disappears within
first 6–8 weeks)
None beyond first 6–8 weeks
III (1 small-to-medium
coronary artery aneurysm/
major coronary artery)
Low-dose aspirin (3–5 mg/kg
aspirin/day), at least until
aneurysm regression
documented
IV (1 large or giant coronary
artery aneurysm, or
multiple or complex
aneurysms in same
coronary artery, without
obstruction)
Long-term antiplatelet therapy and
warfarin (target international
normalized ratio 2.0–2.5) or
low-molecular-weight heparin
(target: antifactor Xa level
0.5–1.0 U/ml) should be
combined in giant aneurysms
V (coronary artery
obstruction)
Long-term low-dose aspirin;
warfarin or low-molecular-weight
heparin if giant aneurysm
persists; consider use of beta-
blockers to reduce myocardial
O2 consumptiondapted from Newburger et al. (6).
ECG  electrocardiogram.ecovered from KD and approximately 8,400 young adults who
re classified as AHA risk level II or greater (7). The number
f adults classified as risk level II or greater will grow by an
stimated 1,400 individuals each year. These numbers are
learly underestimated because many KD patients were older
han 2 years at the time of disease onset and many clinical cases
ere never diagnosed. Whatever the real figures are, there is
learly a growing population of young adults with potentially
mportant coronary artery disease after KD in childhood, and
ardiologists specializing in adult patients must be prepared to
are for them.
ardiovascular Sequelae of KD in Adults
nly in Japan has an attempt been made to systematically
ollect mortality data on patients with KD. During a 10-year
eriod from 1982 to 1992, a cohort of 6,576 Japanese patients
as created, and the seventh report on the status of the cohort
as recently published (20). As of 2004, there were 3,326 adult
ubjects in the cohort ages 20 to 34 years with an average
bservation period of approximately 17 years. Standardized
ortality ratios (SMRs) were calculated for subsets in the
ohort based on sex, coronary artery sequelae, and timing of
eath after KD. After the acute phase, the SMR was increased
nly for male patients with known cardiovascular sequelae
expected deaths: 3.9, observed deaths: 10; SMR 2.55, 95%
onfidence interval: 1.23 to 4.70). The cause of death in these
0 male patients was listed as coronary artery insufficiency
n  2), acute myocardial infarction (n  3), sudden death
n 1), congestive heart failure (n 1), influenza pneumonia
i Disease
ollow-Up and Diagnostic Testing Invasive Testing
ardiovascular risk assessment,
counseling at 5-yr intervals
None recommended
ardiovascular risk assessment,
counseling at 3- to 5-yr intervals
None recommended
nnual cardiology follow-up with
echocardiogram  ECG,
combined with cardiovascular
risk assessment, counseling;
biennial stress test/evaluation
of myocardial perfusion scan
Angiography, if noninvasive test
suggests ischemia
iannual follow-up with
echocardiogram  ECG; annual
stress test/evaluation of
myocardial perfusion scan
First angiography at 6–12 months or
sooner if clinically indicated;
repeated angiography if
noninvasive test, clinical, or
laboratory findings suggest
ischemia; elective repeat
angiography under some
circumstances
iannual follow-up with
echocardiogram and ECG;
annual stress test/evaluation of
myocardial perfusion scan
Angiography recommended to
address therapeutic optionsseasak
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November 17, 2009:1911–20 Sequelae of Kawasaki Disease in Adultsn 1), and suicide (n 2), with deaths occurring between 11
onths to 18 years after onset of KD. Unfortunately, only
ortality data are available on the cohort, and no information
s available on the clinical status of these subjects.
Late complications of KD may include residual damage
rom the acute vasculitis as well as the myocarditis (21). In
he only longitudinal angiographic study of KD, Kato et al.
3) described the natural history of the vascular lesions in
94 Japanese subjects 10 to 12 years after the onset of KD
Fig. 1). This study was performed before the routine use of
VIG to treat acute KD. Long-term complications included
tenosis, myocardial infarction, and death. Other series have
eported both symptomatic and asymptomatic coronary
rtery occlusion in regions of previous aneurysms (22,23),
oronary artery stenosis (24), coronary artery calcification
25), diastolic dysfunction (26), and sudden death (27). One
tudy by Tsuda et al. (28) of 562 Japanese KD patients with
nown coronary artery lesions documented the appearance
f new aneurysms 2 to 19 years after disease onset in 15
atients (3%). Patients with KD with aneurysms at least 6
Figure 1 Sequential Angiographic Evaluation During a 10- to 21
of Japanese Patients With KD Who Developed Corona
Adapted, with permission, from Kato et al. (3). F/u  follow-up; KD  Kawasaki dm in maximal diameter had a greater than 50% chance of 1eveloping a clinically significant stenotic lesion during a
ean follow-up period of 8 years (24). Most of these series
re from Japan, and none report longitudinal outcome in
D patients who were treated with IVIG during the acute
llness. On the basis of the accumulating evidence, it is likely
hat patients with known aneurysms during the acute phase
f KD will have some cardiovascular morbidity as young
dults. The fate of IVIG-treated children who had no
esions detected by echocardiography as a result of the acute
asculitis is unknown (Figs. 2A and 2B).
During acute KD, approximately 2% of patients will
evelop valvulitis, followed by scarring of the valve leaflets,
ost commonly in the mitral valve, leading to valvular
ncompetence and the need for valve replacement in a subset
f patients (29–31). Another manifestation of the cardio-
ascular damage after acute KD is the progressive dilation of
he aortic root (32). In a longitudinal study of 100 children
ith KD, the body surface area-adjusted aortic root dimen-
ion was significantly larger when compared with control
ubjects. Mild aortic valve regurgitation was noted at the
r-Period
tery Aneurysms
; MI  myocardial infarction.-Yea
ry Ar
isease-year visit in 4% of KD patients (32,33).
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Sequelae of Kawasaki Disease in Adults November 17, 2009:1911–20Focus on the coronary aneurysms has diverted attention
rom other potential cardiovascular complications of KD.
iffuse myocarditis followed by myocardial fibrosis may
ead to systolic or diastolic dysfunction in a subset of KD
atients (34–36). During acute KD, tissue Doppler inter-
ogation of left ventricular inflow velocities has revealed
bnormal relaxation patterns and was associated with in-
reased levels of B-type natriuretic peptide (35). Decreased
entricular contractility and abnormal relaxation may be the
onsequences of antecedent myocardial inflammation, and
ate-onset ventricular arrhythmias and congestive heart fail-
re have been observed (21,37).
issed KD Presenting in Adulthood
n 1992, Kato et al. (38) in Japan published the results of a
Figure 2 Histology of Kawasaki Disease
Autopsy findings in a 19-year-old man who developed severe cardiomyopathy
17 years after Kawasaki disease at age 2 years treated with intravenous
immunoglobulin. Echocardiography during the acute and convalescent phase
showed normal internal dimensions of the coronary arteries. (A) Masson
trichrome stain of a branch of the right coronary artery showing late organiza-
tion of a thrombus. Original magnification 40. (B) Masson trichrome stain of
left ventricle showing endocardial fibrosis with an organizing subendocardial
microinfarct. Original magnification 100. Photos courtesy of Dr. Henry F.
Krous, Director of Pathology Research, Rady Children’s Hospital, San Diego,
California.uestionnaire survey sent to adult cardiologists that asked wbout adult patients with angiographically proven coronary
rtery disease that could reasonably be attributed to ante-
edent KD. The survey identified 130 patients ages 20 to 63
ears: 21 adults had ischemic heart disease definitely (n 2)
r possibly (n  19) attributed to antecedent KD, and 109
dults had coronary artery aneurysms with no clear history
f clinical KD in childhood. Of the 21 patients with a high
ikelihood of antecedent KD, 3 had died of ischemic
omplications, and 18 were alive with serious cardiovascular
equelae, including mitral regurgitation requiring valve re-
lacement, arrhythmias, dilated cardiomyopathy, and con-
estive heart failure. The authors concluded that all 130
atients likely had KD as the cause of their vascular damage
nd that cardiologists specializing in adult patients should
e aware of these patients in their clinical practice. No
ubsequent survey from Japan or elsewhere has been per-
ormed to estimate the number of adult patients under the
are of a cardiologist for the sequelae of KD.
Young adults with no known previous cardiovascular
istory may present with angina, myocardial infarction,
schemia-induced arrhythmia, or sudden death (39). Char-
cteristics of the coronary arteries that should prompt
uestioning about antecedent KD include proximal aneu-
ysms with or without calcification followed by an angio-
raphically normal distal segment. Young adults in Japan
ave presented with ventricular tachycardia in the setting of
eft heart failure decades after missed KD (37). Investigation
f these patients revealed the classic calcified aneurysms of
D. Thus, the acute vasculitis and myocarditis associated
ith KD may lead to a complex set of cardiovascular
roblems later in life.
athology
lthough the term “atherosclerosis” has been loosely applied
o the progressive vascular lesion after KD, evidence sug-
ests that this is a misnomer. Although many autopsy
eports of individuals who died late after KD describe
alcified aneurysms, myointimal proliferation, and organiz-
ng thrombus in the coronary arteries with recanalization,
here is scant mention of lipid-laden macrophages and
holesterol crystals, the hallmarks of established atheroscle-
osis (40,41). There is ample histological evidence to sup-
ort the concept that coronary arteries that develop aneu-
ysms as a result of the intense inflammatory process during
cute KD have very abnormal architecture despite normal-
zation of the lumen and angiographic evidence of “healing”
42,43). The typical lesions are discrete regions of myointi-
al proliferation associated with disrupted internal elastic
amina and medial smooth muscle cell necrosis with replace-
ent by fibrosis and calcification. Suzuki et al. (44) exam-
ned 7 subjects at autopsy who died 3 to 12 years after acute
D. Active remodeling of the aneurysms with intimal
roliferation and neoangiogenesis was evident in all cases.
one of the subjects had coronary artery lesions consistent
ith atherosclerosis. Takahashi et al. (45) described a series
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November 17, 2009:1911–20 Sequelae of Kawasaki Disease in Adultsf 6 subjects with arterial lesions who died from either
udden death (n 5) or sepsis (n 1) at least 15 years after
cute KD. Only 1 of the 6 subjects had pathology consistent
ith atherosclerosis. No clinical details were provided in
his report, so it is unknown whether this 39-year-old
ubject with typical atherosclerotic lesions had cardiovascu-
ar risk factors superimposed on his antecedent KD. The
xtent to which KD is a cardiovascular risk factor for the
uture development of atherosclerosis is unknown.
Another controversial issue is the pathology of arteries in
VIG-treated individuals whose echocardiograms showed
o evidence of structural damage to the coronary artery wall.
he scant autopsy data available on the histological changes
n children and young adults who have died late after KD
ppear as case reports, many of them in the forensic
iterature (39). In an autopsy study of a child who died from
nrelated causes 13 months after recovery from KD with
ormal echocardiograms, the intima of the coronary artery
as thickened, the internal elastic lamina was disrupted, and
mooth muscle cells were observed infiltrating into the
ntima (46). Further autopsy studies of incidental deaths in
ubjects with antecedent KD and normal echocardiograms
ill be necessary to determine how often KD leads to
athologic changes in coronary arteries with no dilation
oted during the acute phase of the illness. A prospective
egistry of KD cases would allow tracking of deaths and
orrelation of the histopathology with echocardiographic
ssessment during the acute illness.
Pathologic changes in the myocardium as a result of
njury during the acute inflammatory phase also have been
eported. Three series from Japan reported endomyocardial
iopsies at various time points after the acute illness
47–49). In the study by Yonesaka et al. (48) hypertrophy,
egeneration of myocytes, and fibrosis were noted in the
ajority of biopsies obtained at least 3 years after KD in 38
ubjects, and their presence was more frequent in subjects
ho had experienced coronary artery aneurysms during the
cute phase. Yutani et al. (47,50) found myocardial abnor-
alities, including lymphocyte and plasma-cell infiltration,
yocardial fibrosis, and disarray of myocardial fibers in
very biopsy from the 201 KD subjects in their study.
hanges were most pronounced in patients studied 4 or
ore years after disease onset and the investigators raised
he question of progression of myocardial pathology over
ime.
Some autopsy reports of adults late after KD describe
ardiomyocyte dropout and diffuse fibrosis not in the wa-
ershed distribution of the epicardial coronary arteries (Fig.
B) (51–53). Increasing numbers of deaths that are attrib-
ted to left ventricular dysfunction and presumed ventricu-
ar arrhythmias are being reported in young adults from
apan with antecedent KD (27). Whether the diffuse fibrosis
s a consequence of ischemic injury from microinfarcts or
nflammatory cardiomyocyte injury or both is unknown. tndothelial-Cell Dysfunction
nd Arterial Wall Injury
n addition to causing coronary artery aneurysms and
tenoses, KD also has been shown to have deleterious effects
n coronary artery function years after the acute presenta-
ion. Arterial function has been assessed in multiple studies
n which the authors evaluated myocardial and coronary
ow reserve with angiography (54 –57), invasive flow
easurements (58–60), positron emission tomography
61–63), and transthoracic Doppler ultrasound of the cor-
nary arteries (64). Abnormalities have been observed in
ndothelial-mediated as well as endothelial-independent
oronary artery vasodilation. In patients with persistent
oronary artery aneurysms, coronary artery function has
epeatedly been shown to be impaired compared with
ontrol subjects (56,57,59–61,64). Coronary flow reserve is
lso abnormal in patients with a history of transiently
ilated coronary arteries (54–57,60–62) and in patients
ith evidence of inducible ischemia but angiographically
ormal-appearing coronary arteries (58,59). Even in pa-
ients with a history of KD without antecedent coronary
rtery dilation or ischemia, impaired coronary flow reserve
as been observed (54,60,61,63,64), although conflicting
tudies showed no difference from normal control subjects
55–57). Thus, the damage to coronary arteries appears to
xtend beyond that which is observed angiographically.
Studies of systemic vascular function via flow-mediated
ilation of the brachial artery have yielded conflicting
esults. Dhillon et al. (65) demonstrated abnormal brachial
rtery reactivity in 20 male subjects in the United Kingdom
ges 11 to 19 years who were studied 5 to 17 years after the
nset of KD, irrespective of whether they had developed
neurysms during the acute phase. In studies of Japanese
ubjects of approximately the same age and interval from
isease onset, only patients with previous aneurysms had
bnormal flow-mediated dilation (66,67). Finally, the au-
hors of a recent study (68) of 52 Canadian KD subjects
oncluded that there was no evidence of long-term
ndothelial-cell dysfunction late after KD. It is unclear
hether these conflicting results are best explained by
ethodological issues or genetic differences of the popula-
ions studied. Metabolic abnormalities manifested as abnor-
al lipid profiles with persistently low high-density lipopro-
ein may also contribute to endothelial cell dysfunction
69,70).
Carotid intimal medial thickness (IMT) measured non-
nvasively by ultrasound is used as a surrogate marker of
oronary atherosclerosis and has been correlated with the
isk of stroke and myocardial infarction in adults with
therosclerosis (71). The authors of several small studies
ave demonstrated increased carotid IMT in patients who
ave recovered from KD, but the significance of this
bservation is unclear (66,72–74). Patients with remodeled
oronary aneurysms have even greater carotid IMT than
hose without aneurysms. However, no study to date has
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Sequelae of Kawasaki Disease in Adults November 17, 2009:1911–20orrelated clinical outcomes with IMT findings in KD
atients. There is no evidence that increased carotid IMT in
D patients implies atherosclerosis and the prognostic
ignificance of this measurement is unknown.
dentifying the Adult With Possible Antecedent KD
he cardiologist specializing in adult patients should be
ufficiently familiar with the signs and symptoms of acute
D to allow questioning of the patient or parent about an
ntecedent KD-compatible illness that was not diagnosed.
eatures of the illness that are frequently recalled by patients
nd parents are the prolonged fever, rash, “bloodshot” eyes
Figure 3 Calcification of Coronary Artery
Multislice computed tomography angiogram showing extensive calcification of a
left anterior descending coronary artery aneurysm in a 12-year-old male patient
7 years after acute Kawasaki disease.
Figure 4 Occlusion of the RCA
Angiogram of occluded right coronary artery (RCA) aneurysm in a 33-year-old man w
nonspecific viral illness) and was asymptomatic until his myocardial infarction. (A)
plasty with re-established distal flow. Note smooth appearance of distal branches
nary angioplasty, aspirin, and warfarin therapy maintaining an international normaln the acute phase, and peeling of the fingers and toes in the
onvalescent phase. Common misdiagnoses for KD include
iral syndrome, measles, scarlet fever, allergic reaction to
ntibiotics, and Stevens-Johnson syndrome (4). Because the
tiology remains unknown, there is no specific diagnostic
est that can be used to make a retrospective diagnosis.
Imaging studies may be helpful in identifying patients
ith antecedent KD (Level of Evidence [LOE]: C, Class
Ia). Calcification of the arterial wall in regions where
ormer aneurysms have remodeled are hallmarks of KD and
ay even be apparent on chest radiograph (41,75). In a
tudy of Japanese young adults 20 years after acute KD, 94%
f those with aneurysms at least 6 mm in internal diameter
uring the subacute phase of the illness had calcification
bserved by electron beam computed tomography (CT)
76). Arterial-wall calcification can be also be imaged by
ultislice CT angiography (Fig. 3). Coronary calcium
cores are elevated in a subset of KD subjects with anteced-
nt vascular injury (77). Suspicion of antecedent KD should
e high in the young adult with coronary artery calcification
nd a low-risk profile for atherosclerosis.
Differentiation of atherosclerotic aneurysms from KD
ay be aided by angiography (LOE: C, Class IIb). Whereas
therosclerosis tends to involve the arterial wall diffusely,
D results in focal abnormalities only at the site of previous
neurysms. Vessels proximal and distal to the lesion appear
ealthy and have a smooth luminal surface and normal
iameter (Fig. 4). Remodeled aneurysms of KD may be
ore difficult to recognize, and intravascular ultrasound may
e useful to detect the thickened arterial wall of the
neurysm (78,79).
perienced a Kawasaki disease-compatible illness at age 6 years (diagnosed as
ion of the occluded RCA (B) RCA after percutaneous transluminal coronary angio-
RCA. (C) Patent RCA aneurysm 1 month after percutaneous transluminal coro-
tio of 2 to 2.5.ho ex
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November 17, 2009:1911–20 Sequelae of Kawasaki Disease in AdultsMagnetic resonance (MR) imaging is emerging as the
odality of choice for imaging structural damage late after
D (LOE: C, Class IIa). Repeated imaging is possible
ithout concerns for radiation exposure. Myocardial in-
ammation with the use of T2-weighted images as well as
yocardial scarring and fibrosis can be detected as late
adolinium enhancement (80–82). At the present time,
adolinium MR angiography is not as sensitive as CT
ngiography or cardiac catheterization for the detection of
oronary artery stenosis (80).
anagement of the Adult With Antecedent KD
he optimal management of adults with antecedent KD can
nly be established through systematic study of this patient
opulation with the creation of regional or national regis-
ries to record patient histories and outcomes and generate
ypotheses regarding their care that could be tested in
ppropriately powered clinical studies. One challenge of
tudies designed to collect cardiovascular outcome data will
e to differentiate the effects of antecedent KD from the
ffects of traditional cardiovascular risk factors, which will
ccumulate as this population ages. For now, the manage-
ent of these patients must be guided by common sense
nd an appreciation of the uncertainty about the cardiovas-
ular outcomes in adults who experienced KD in childhood.
he Japanese Circulation Society published guidelines (83)
ased on the opinion of experts in Japan in 2003 for the
anagement and treatment of adults who had KD in
hildhood (Table 2). The guidelines state that cardiovascu-
ar symptoms in KD patients only begin to appear 2 decades
fter the onset of the acute disease, so only now are patients
eginning to present with sequelae.
As with all clinical practice, the admonishment of pri-
um non nocere must be heeded. Subjecting otherwise-
ealthy, asymptomatic individuals to frequent testing may
ave undesirable psychological consequences. At the same
ime, ignoring a past history of KD may lead to missed
pportunities for intervention in a subset of these patients.
rational approach to these patients might include stan-
ard testing for cardiovascular risk assessment as well as
pecific testing to detect subclinical ischemia, valvular dys-
unction, and myocardial fibrosis caused by antecedent KD.
Guidelines for Diagnosis and Management of CaDisease as Outl ned by the Jap es CirculationTable 2 Guideli e for Di gnosis and M nagDisease as Outlined by the Japanes
Patient Risk Level
AHA risk level 1 and 2 Cons
AHA risk level 3, 4, 5 without symptoms Evalu
ev
AHA risk level 3, 4, 5 with symptoms Evalu
as
dic
Data from the Japanese Circulation Society (83). *Noninvasive testing
echocardiogram, magnetic resonance angiography, and computed tom
AHA  American Heart Association.esting might include a lipid profile, high sensitivity g-reactive protein level, electrocardiogram, 2-dimensional
ransthoracic echocardiogram, and stress echocardiogram
LOE: C, Class IIb). Because arterial calcification is a
eature of KD vascular lesions, a single, baseline coronary
rtery calcium score by CT may be informative, particularly
or patients whose initial evaluation by echocardiogram in
hildhood was technically inadequate or for whom the
esults are unknown (77) (LOE: C, Class IIb). Magnetic
esonance imaging can be used to detect small myocardial
cars and fibrosis that cannot be detected by other modali-
ies, and thus cardiac MR imaging also may be useful in the
aseline evaluation of this patient population (LOE: C,
lass IIb). Noninvasive assessments of endothelial-cell
unction such as brachial artery flow-mediated dilation and
tructural assessments such as carotid IMT remain research
ools at this time with uncertain prognostic significance.
ollow-up evaluations every 3 to 5 years are currently
ecommended for KD patients during childhood, and con-
inuing this periodic reassessment into adulthood seems
rudent given the lack of information about the long-term
onsequences of KD (6). No medication is currently recom-
ended for this patient population.
Adults with persistent or regressed aneurysms should be
ollowed at regular intervals with functional and structural
ardiovascular studies to determine the need for interven-
ions (LOE: B, Class IIa). When considering CT, cardiac
atheterization, or nuclear medicine studies, consideration
hould be given to the young age of these adults and the
eed for life-long, repeated assessments when weighing the
isks versus the benefits of the radiation exposure. Although
epeated MR imaging is without known risk, CT angiog-
aphy provides a better assessment of coronary artery ste-
osis and calcification. Future improvements in software
nd cardiac cycle gaiting techniques will likely reduce the
adiation exposure.
Optimal pharmacologic therapy of adult patients with
ersistent or regressed aneurysms has not been established.
he AHA guidelines advocate the use of aspirin as an
ntiplatelet agent (3 to 5 mg/kg/day) in children with
mall-to-moderate aneurysms (8 mm) (Table 1) (6).
iclopidine or clopidogrel are also added to aspirin therapy
t some centers (LOE: C, Class IIb). The current AHA
ascular Sequelae in Kawasakiietynt of Cardiovascular Sequel e in Kawasaki
culation Society
Recommendation
ninvasive testing every 3–4 yrs.* No medical therapy.
ery 4–6 months with noninvasive testing and angiography
years. Treat with low-dose aspirin.
ery 3–4 months with noninvasive testing and angiography
d. Treat with low-dose aspirin; other medications as
by the cardiovascular status.
se testing, nuclear imaging studies, Holter monitor, transesophageal
hy angiogram.rdiovS ceme
e Cir
ider no
ate ev
ery 2–3
ate ev
neede
tated
: exerciuidelines suggest discontinuation of antiplatelet therapy
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he use of 3-hydroxy-3-methylglutaryl-coenzyme A reduc-
ase inhibitors, angiotensin-converting enzyme inhibitors,
nd angiotensin receptor blockers may all mobilize endo-
helial progenitor cells and promote vascular wall remodel-
ng, although there are no data to support their use in the
etting of KD (84,85).
For KD patients with persistent aneurysms, treatment
egimens should be tailored on the basis of the size of the
neurysm and flow characteristics. In patients with giant
neurysms (8 mm) in which blood flow is sluggish and
isk for thrombosis is high, systemic anticoagulation with
arfarin with an international normalized ratio between 2.0
nd 2.5 has been associated with improved survival in small
eries of KD patients from Canada and Japan (LOE: B,
lass IIa) (86,87). There are no data to inform the man-
gement of adult patients with large aneurysms, but con-
inuation of systemic anticoagulation seems reasonable.
ddition of aspirin for platelet inhibition should also be
onsidered (LOE: C, Class IIa).
On the basis of available data, pregnancy in KD patients
ith persistent aneurysms is not associated with increased
isk (88–90). The authors of a nationwide survey (91) in
apan reported the outcome of 46 deliveries in 30 KD
atients. Two-thirds of the deliveries were vaginal. Mothers
ith persistent giant aneurysms were given subcutaneous
ow-molecular-weight heparin and low-dose aspirin during
he pregnancy. There were no cardiac complications, and
he authors concluded that the mode of delivery should be
ictated by obstetrical considerations and that coronary
rtery aneurysms alone were not an indication for Caesarean
elivery (LOE: B, Class IIb).
Percutaneous catheter interventions may be necessary if
arrowing of the vessel lumen leads to signs or symptoms of
schemia (LOE: B, Class IIa). Ishii et al. (92) have devel-
ped consensus guidelines for the use of these procedures in
hildhood. Percutaneous transluminal angioplasty has been
omplicated by the need for very high balloon pressures in
ighly calcified lesions leading to neoaneurysm formation
93). There is limited experience with revascularization
rocedures that use covered or drug-eluting stents in this
atient population (94,95). Rotational atherectomy is the
nterventional procedure of choice for heavily calcified,
tenotic lesions that are not amenable to percutaneous
ransluminal angioplasty, although current experience is
imited (LOE: C, Class IIa) (96).
Surgical approaches that use both venous and arterial
rafts have been used in this patient population (LOE: B,
lass IIa). In a survey of 156 KD patients older than 12
ears treated with internal thoracic artery grafts, the patency
ate at 15 years was 91% (97). Use of arterial grafts in
atients with large growth potential resulted in a much
reater rate of graft patency over time as compared with
enous grafts. Surgical intervention in young adults with
neurysms after KD has been reported (98). Surgical risks
nd graft survival did not differ from those of patientsndergoing similar procedures for ischemia due to athero-
clerotic disease.
Cardiac transplantation has been successfully performed for
D patients with end-stage cardiomyopathy, severe ventricular
rrhythmias, and inoperable multivessel stenotic coronary ar-
ery disease (99). There has been no recurrence of KD or
oronary artery aneurysms in the transplanted hearts, and all
orbidity and mortality in this cohort have been related to
ejection and complications of immunosuppression.
onclusions
n the coming years, growing numbers of patients with
ardiovascular complications after KD will present to inter-
ists and cardiologists specializing in adult patients for care.
he vascular lesions in these patients differ from atheroscle-
osis and may include coronary artery aneurysms, calcifica-
ion, and stenosis. These patients may also present with
alvular incompetence due to scarring of the leaflets or
rogressive aortic root dilation and myocardial lesions,
ncluding diffuse fibrosis or focal scarring in regions of
yocardial ischemia or infarct. The inflammatory insult
ssociated with acute KD has the potential to affect all
omponents of the cardiovascular system. Systematic study
f adults with a history of KD in childhood is needed to
efine the natural history of this enigmatic disease.
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